Treatment of hypothyroidism in infants, children and adolescents

Trends Endocrinol Metab. 2022 Jul;33(7):522-532. doi: 10.1016/j.tem.2022.04.007. Epub 2022 May 7.

Abstract

In 2014, treatment guidelines from the American Thyroid Association reflected the general consensus that levothyroxine (LT4), adjusted to maintain a normal thyrotropin (TSH) level, is the preferred method for treatment of hypothyroidism. Although this is generally applicable to children, there are subsets of children for whom the diagnosis and treatment of hypothyroidism are problematic. These include children with congenital hypothyroidism (CH), low birth weight (LBW) and very low birth weight (VLBW), Down syndrome (DS), subclinical hypothyroidism, and obesity. In this Review, we focus on the progress and remaining pitfalls in diagnosis and treatment of hypothyroidism in these and other groups.

Keywords: acquired; children; congenital; hypothyroidism; levothyroxine; therapy; triiodothyronine.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Humans
  • Hypothyroidism* / diagnosis
  • Hypothyroidism* / drug therapy
  • Infant
  • Thyrotropin / therapeutic use
  • Thyroxine / therapeutic use
  • Triiodothyronine* / therapeutic use

Substances

  • Triiodothyronine
  • Thyrotropin
  • Thyroxine